AI-Sight develops AI-driven diagnostic technology for early detection and treatment of diabetic retinopathy.

Glasgow diagnostics spinout Microplate Dx has closed a £2.5 million seed funding round to develop its point-of-care diagnostic platform, which can confirm the presence of bacteria and rapidly identify effective antibiotics to use and which ones to avoid.